Free Trial

Heritage Financial Services LLC Takes Position in CVS Health Corporation $CVS

CVS Health logo with Medical background

Key Points

  • Heritage Financial Services LLC acquired a new stake in CVS Health Corporation, purchasing 3,828 shares valued at approximately $259,000 in the first quarter.
  • Several large investors increased their positions in CVS, with notable acquisitions including Wellington Management Group LLP, which boosted its stake by 83.2% to own 403,365 shares valued at $27.3 million.
  • CVS Health reported a quarterly earnings EPS of $1.81, surpassing estimates and generated revenue of $98.92 billion, reflecting an increase of 8.4% compared to the previous year.
  • Need better tools to track CVS Health? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Heritage Financial Services LLC purchased a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,828 shares of the pharmacy operator's stock, valued at approximately $259,000.

Several other large investors have also recently modified their holdings of CVS. Vanguard Group Inc. increased its stake in CVS Health by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock worth $8,017,223,000 after purchasing an additional 969,027 shares during the period. Invesco Ltd. increased its stake in shares of CVS Health by 13.2% in the first quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock worth $1,383,039,000 after buying an additional 2,375,764 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in CVS Health by 5.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock valued at $924,643,000 after buying an additional 728,924 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in CVS Health by 14.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,366,403 shares of the pharmacy operator's stock worth $600,019,000 after acquiring an additional 1,660,321 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of CVS Health by 0.5% in the first quarter. Northern Trust Corp now owns 12,555,958 shares of the pharmacy operator's stock valued at $850,666,000 after acquiring an additional 64,002 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 0.4%

CVS Health stock traded down $0.2560 on Friday, hitting $71.1740. 6,982,068 shares of the stock traded hands, compared to its average volume of 8,748,738. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The firm has a market cap of $90.27 billion, a P/E ratio of 19.88, a price-to-earnings-growth ratio of 0.79 and a beta of 0.58. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The business's fifty day simple moving average is $65.50 and its 200 day simple moving average is $65.18.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health's revenue was up 8.4% on a year-over-year basis. During the same period last year, the company posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.7%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio is currently 74.30%.

Insider Activity

In other news, Director Guy P. Sansone purchased 1,570 shares of CVS Health stock in a transaction that occurred on Thursday, June 5th. The stock was bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.22% of the company's stock.

Analyst Ratings Changes

CVS has been the topic of several recent analyst reports. Cowen reissued a "buy" rating on shares of CVS Health in a research note on Monday, August 4th. Truist Financial boosted their target price on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Finally, Barclays upped their price objective on shares of CVS Health from $79.00 to $80.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, CVS Health has a consensus rating of "Buy" and an average target price of $76.67.

Check Out Our Latest Report on CVS Health

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines